BAY 60–6583
Chemical compound
From Wikipedia, the free encyclopedia
BAY 60–6583 is a selective adenosine A2B receptor agonist.[1] It has been shown to provide protection from ischemia (lack of oxygen due to blocked blood supply) in both the heart and kidney of test animals,[2][3] and has also been shown to be beneficial in treatment of acute lung and brain injury,[4][5] as well as claimed anti-aging and anti-obesity effects,[6] showing a range of potential applications for selective A2B agonists.
| Names | |
|---|---|
| Preferred IUPAC name
2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide | |
| Other names
BAY 60–6583 | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C19H17N5O2S | |
| Molar mass | 379.435 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
